Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Elective surgery
Pandemic
DOI:
10.1200/jco.20.01933
Publication Date:
2020-10-06T19:59:28Z
AUTHORS (3647)
ABSTRACT
PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective is best performed. This study aimed whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared hospitals no defined pathway. PATIENTS AND METHODS international, multicenter cohort included patients who underwent for 10 solid types without preoperative suspicion of SARS-CoV-2. Participating from local emergence SARS-CoV-2 until April 19, 2020. At time surgery, as having a pathway (complete segregation operating theater, critical care, and inpatient ward areas) or (incomplete segregation, areas shared COVID-19). The primary outcome was 30-day complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 447 in 55 countries, 2,481 operated on pathways. Patients within younger fewer comorbidities than those but similar proportions major surgery. After adjustment, (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 0.86). consistent sensitivity analyses low-risk (American Society Anesthesiologists grade 1/2), propensity score–matched models, negative tests. infection rate also (2.1% 3.6%; aOR, 0.53; 0.36 0.76). CONCLUSION Within available resources, dedicated should be established provide safe during current before future outbreaks.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (160)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....